Results 31 to 40 of about 101,188 (209)

Limitation of life-sustaining treatment and patient involvement in decision-making: a retrospective study of a Danish COVID-19 patient cohort

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2021
Background The coronavirus (COVID-19) pandemic and the risk of an extensive overload of the healthcare systems have elucidated the need to make decisions on the level of life-sustaining treatment for patients requiring hospitalisation. The purpose of the
Hanne Irene Jensen, Sevim Ozden, Gitte Schultz Kristensen, Mihnaz Azizi, Siri Aas Smedemark, Christian Backer Mogensen   +5 more
doaj   +1 more source

Effect of shared decision-making education on physicians’ perceptions and practices of end-of-life care in Korea [PDF]

Kidney Research and Clinical Practice, 2022
Background Evidence of the ethical appropriateness and clinical benefits of shared decision-making (SDM) are accumulating. This study aimed to not only identify physicians’ perspectives on SDM, and practices related to end-of-life care in particular, but
Byung Chul Yu, Miyeun Han, Gang-Jee Ko, Jae Won Yang, Soon Hyo Kwon, Sungjin Chung, Yu Ah Hong, Young Youl Hyun, Jang-Hee Cho, Kyung Don Yoo, Eunjin Bae, Woo Yeong Park, In O Sun, Dongryul Kim, Hyunsuk Kim, Won Min Hwang, Sang Heon Song, Sung Joon Shin   +17 more
doaj   +1 more source

Hemodialysis as a life-sustaining treatment at the end of life

Kidney Research and Clinical Practice, 2018
The Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life came into effect on February 4th, 2018, in South Korea.
Sung Joon Shin, Jae Hang Lee
doaj   +1 more source

The Current Status of Medical Decision-Making for Dying Patients in a Medical Intensive Care Unit: A Single-Center Study [PDF]

Korean Journal of Critical Care Medicine, 2014
BACKGROUND: Many terminally ill patients die while receiving life-sustaining treatment. Recently, the discussion of life-sustaining treatment in intensive care units (ICUs) has increased.
Kyunghwa Shin, Jeong Ha Mok, Sang Hee Lee, Eun Jung Kim, Na Ri Seok, Sun Suk Ryu, Myoung Nam Ha, Kwangha Lee   +7 more
doaj   +1 more source

A Quality Improvement Initiative to Increase Completion and Documentation of Advanced Directives in the ICU at a U.S. Community Teaching Hospital

Critical Care Explorations, 2021
Objectives:. Advance directives can help guide care in the ICU. As a healthcare quality improvement initiative, we sought to increase the percentage of patients with a healthcare power of attorney and/or practitioner orders for life-sustaining treatment ...
Kristin L. Walter, MD, MS, Hillarie E. Joehl, MS, ACNP-BC, ACHPN, RN, Taha Alrifai, MD, Thomas G. Varghese, MD, Matthew J. Tyler, MD   +4 more
doaj   +1 more source

The effects of hospice care on healthcare expenditure among cancer patients

BMC Health Services Research, 2023
Purpose It is necessary to estimate the hospice usage and hospice-related cost for entire cancer patients using nationwide cohort data to establish a suitable ethical and cultural infrastructure.
Hoyol Jhang, Wonjeong Jeong, Hyun-Soo Zhang, Dong-Woo Choi, Hyejung Kang, Sohee Park   +5 more
doaj   +1 more source

Can primary palliative care education change life-sustaining treatment intensity of older adults at the end of life? A retrospective study

BMC Palliative Care, 2021
Background Palliative care education has been carried out in some hospitals and palliative care has gradually developed in mainland China. However, the clinical research is sparse and whether primary palliative care education influence treatment ...
Qian Liu, Mingzhao Qin, Jian Zhou, Hui Zheng, Weiping Liu, Qi Shen   +5 more
doaj   +1 more source

Frequency of Withdrawal of Life-Sustaining Therapy for Perceived Poor Neurologic Prognosis

Critical Care Explorations, 2021
OBJECTIVES:. To measure the frequency of withdrawal of life-sustaining therapy for perceived poor neurologic prognosis among decedents in hospitals of different sizes and teaching statuses. DESIGN:. We performed a multicenter, retrospective cohort study.
Alexis Steinberg, MD, Benjamin S. Abella, MD, MPhil, Emily J. Gilmore, MD, David Y. Hwang, MD, Niki Kennedy, BA, Winnie Lau, MD, Isabelle Mullen, BSc, Nidhi Ravishankar, MD, Charlotte F. Tisch, BA, Adam Waddell, MD, David J. Wallace, MD, MPH, Qiang Zhang, BA, Jonathan Elmer, MD, MSc   +12 more
doaj   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta, Jeremy D. Rubinstein, Christopher E. Dandoy, Ruby Khoury, Angela Faulhaber, Christine L. Phillips, Christa Krupski   +6 more
wiley   +1 more source

Impact of advance directives on the variability between intensivists in the decisions to forgo life-sustaining treatment

Critical Care, 2020
Background There is wide variability between intensivists in the decisions to forgo life-sustaining treatment (DFLST). Advance directives (ADs) allow patients to communicate their end-of-life wishes to physicians.
Margot Smirdec, Mercé Jourdain, Virginie Guastella, Céline Lambert, Jean-Christophe Richard, Laurent Argaud, Samir Jaber, Kada Klouche, Anne Medard, Jean Reignier, Jean-Philippe Rigaud, Jean-Marc Doise, Russell Chabanne, Bertrand Souweine, Jeremy Bourenne, Julie Delmas, Pierre-Marie Bertrand, Philippe Verdier, Jean-Pierre Quenot, Cecile Aubron, Nathanael Eisenmann, Pierre Asfar, Alexandre Fratani, Jean Dellamonica, Nicolas Terzi, Jean-Michel Constantin, Axelle Van Lander, Renaud Guerin, Bruno Pereira, Alexandre Lautrette   +29 more
doaj   +1 more source